Pain Management Drugs Market
Pain Management Drugs Market - Overall Industry Analysis 2025
Progressive Markets published a report, Pain Management Drugs Market - Size, Trend, Share, Opportunity Analysis & Forecast, 2014-2025. As per the report, the market was valued at $ 53267.0 million in 2014 and is likely to garner $ 77255.7 million in 2025, growing at a CAGR of 3.87% during the forecast period.
Pain is an unpleasant physical sensation arising from tissue damage or illness. Moreover, many diseases such as stomach ulcer, fibromyalgia, osteoarthritis, chronic arthritis, multiple sclerosis, diabetic neuropathy, and cancer cause pain. The duration of a pain can be short or long. Short-term pain is referred to as acute pain while long-term pain is referred to as chronic pain. Acute pain is a sudden occurrence of pain, while chronic pain occurs due to the aging of bones & joints, nerve damage, or injury. In order to manage pain, several drugs are available in the market. These drugs either reduce or treat the pain, causing relief to the body.
Market Drivers and Restraints:
The report offers a detailed understanding of the drivers and restraints influencing the pain management drugs market. The industry is driven by the rise in incidences of chronic diseases, favorable regulatory scenario, and an increase in the geriatric population. In addition, advancements in the development of drugs as well as the presence of many untapped markets in the emerging economies provide opportunities for the growth of the market. Nonetheless, availability of alternative therapies, drug exploitation, and patent expiration of prescription drugs act as obstacles to the growth of the market.
Pain Management Drugs Market Key Segmentation:
The report analyzes the pain management drugs market based on the drug class, indication, and geography. Based on type, the industry is bifurcated into NSAIDs, anesthetics, anticonvulsants, anti-migraine agents, antidepressants, opioids, and non-narcotic analgesics. Based on indication, the market is classified as arthritic pain, neuropathic pain, cancer pain, chronic back pain, post-operative pain, migraine, and fibromyalgia. Geographically, the market is studied across North America, Europe, Asia-Pacific, and LAMEA. The pain management drugs market analysis in North America is covered for the U.S., Canada, and Mexico. The market study in Europe covers Germany, France, UK, Italy, Spain, and the rest of Europe. In Asia-Pacific, the market is analyzed across Japan, China, Australia, India, South Korea, Taiwan, and the rest of Asia-Pacific. The market analysis in LAMEA covers Brazil, Saudi Arabia, Republic of South Africa, and the rest of LAMEA.
By Drug Class
The study includes a mention of the emerging players operating in the pain management drugs market. They adopt strategies such as mergers and acquisitions, launches and more to survive and grow in the marketplace. The players in the industry include Novartis AG, Eli Lilly & Company, Abbott Laboratories, Endo Health Solutions, Inc., Purdue Pharma L.P., Pfizer, Inc., F. Hoffmann La Roche Ltd., Merck & Co. Inc., Johnson & Johnson, and GlaxoSmithKline Plc.
Key Benefits from the Report:
The pain management drugs market report offers a comprehensive analysis of the industry with the help of pain management drugs market size, pain management drugs market share, pain management drugs market outlook, pain management drugs market forecast, pain management drugs market trends, market dynamics, Porters Analysis, pain management drugs industry statistics, and major competitors. The report offers the market size to help understand the current and future potential of the market. The market dynamics are explained by offering details on aspects such as the drivers, restraints, and opportunities. The industry statistics helps in assessing the market share and potential. The market share analysis assesses the level of competition within the industry. An analysis of the various aspects of the key industry players such as their financial strategies, recent developments, and summary of their products and services are offered in the study. The current trends and estimations help identify the profitable investment pockets. The Porters Five Forces analysis, which comprises the bargaining power of buyers, bargaining power of suppliers, threat from substitutes, threat of new entrants, and industry rivalry, helps determine the level of competition in the market.
Progressive Markets published a report, Pain Management Drugs Market - Size, Trend, Share, Opportunity Analysis & Forecast, 2014-2025. As per the report, the market was valued at $ 53267.0 million in 2014 and is likely to garner $ 77255.7 million in 2025, growing at a CAGR of 3.87% during the forecast period.
Pain is an unpleasant physical sensation arising from tissue damage or illness. Moreover, many diseases such as stomach ulcer, fibromyalgia, osteoarthritis, chronic arthritis, multiple sclerosis, diabetic neuropathy, and cancer cause pain. The duration of a pain can be short or long. Short-term pain is referred to as acute pain while long-term pain is referred to as chronic pain. Acute pain is a sudden occurrence of pain, while chronic pain occurs due to the aging of bones & joints, nerve damage, or injury. In order to manage pain, several drugs are available in the market. These drugs either reduce or treat the pain, causing relief to the body.
Market Drivers and Restraints:
The report offers a detailed understanding of the drivers and restraints influencing the pain management drugs market. The industry is driven by the rise in incidences of chronic diseases, favorable regulatory scenario, and an increase in the geriatric population. In addition, advancements in the development of drugs as well as the presence of many untapped markets in the emerging economies provide opportunities for the growth of the market. Nonetheless, availability of alternative therapies, drug exploitation, and patent expiration of prescription drugs act as obstacles to the growth of the market.
Pain Management Drugs Market Key Segmentation:
The report analyzes the pain management drugs market based on the drug class, indication, and geography. Based on type, the industry is bifurcated into NSAIDs, anesthetics, anticonvulsants, anti-migraine agents, antidepressants, opioids, and non-narcotic analgesics. Based on indication, the market is classified as arthritic pain, neuropathic pain, cancer pain, chronic back pain, post-operative pain, migraine, and fibromyalgia. Geographically, the market is studied across North America, Europe, Asia-Pacific, and LAMEA. The pain management drugs market analysis in North America is covered for the U.S., Canada, and Mexico. The market study in Europe covers Germany, France, UK, Italy, Spain, and the rest of Europe. In Asia-Pacific, the market is analyzed across Japan, China, Australia, India, South Korea, Taiwan, and the rest of Asia-Pacific. The market analysis in LAMEA covers Brazil, Saudi Arabia, Republic of South Africa, and the rest of LAMEA.
By Drug Class
- NSAIDs
- Anesthetics
- Anticonvulsants
- Antimigraine Agents
- Antidepressants
- Opioids
- Nonnarcotic Analgesics
- Arthritic Pain
- Neuropathic Pain
- Cancer Pain
- Chronic Back Pain
- Postoperative Pain
- Migraine
- Fibromyalgia
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- Taiwan
- India
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
The study includes a mention of the emerging players operating in the pain management drugs market. They adopt strategies such as mergers and acquisitions, launches and more to survive and grow in the marketplace. The players in the industry include Novartis AG, Eli Lilly & Company, Abbott Laboratories, Endo Health Solutions, Inc., Purdue Pharma L.P., Pfizer, Inc., F. Hoffmann La Roche Ltd., Merck & Co. Inc., Johnson & Johnson, and GlaxoSmithKline Plc.
Key Benefits from the Report:
The pain management drugs market report offers a comprehensive analysis of the industry with the help of pain management drugs market size, pain management drugs market share, pain management drugs market outlook, pain management drugs market forecast, pain management drugs market trends, market dynamics, Porters Analysis, pain management drugs industry statistics, and major competitors. The report offers the market size to help understand the current and future potential of the market. The market dynamics are explained by offering details on aspects such as the drivers, restraints, and opportunities. The industry statistics helps in assessing the market share and potential. The market share analysis assesses the level of competition within the industry. An analysis of the various aspects of the key industry players such as their financial strategies, recent developments, and summary of their products and services are offered in the study. The current trends and estimations help identify the profitable investment pockets. The Porters Five Forces analysis, which comprises the bargaining power of buyers, bargaining power of suppliers, threat from substitutes, threat of new entrants, and industry rivalry, helps determine the level of competition in the market.
1. EXECUTIVE SUMMARY
1.1.Key Findings
1.2.Market Attractiveness and Trend analysis
1.3.Competitive Landscape and recent industry development analysis
2. INTRODUCTION
2.1.Report Description
2.2.Scope and Definitions
2.3.Research Methodology
3. MARKET LANDSCAPE
3.1.Growth Drivers
3.1.1. Impact Analysis
3.2.Restrains and Challenges
3.2.1. Impact Analysis
3.3.Porter’s Analysis
3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Industry rivalry
3.3.5. Threat of new entrants
3.4.Global Pain Management Drugs Market Shares Analysis, 2014-2025
3.4.1. Global Pain Management Drugs Market by drug class, 2014-2025
3.4.2. Global Pain Management Drugs Market by indication, 2014-2025
3.4.3. Global Pain Management Drugs Market by region, 2014-2025
4. GLOBAL PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS
4.1.NSAIDs
4.1.1. Historical Market Size by Region, 2014-2016
4.1.2. Market Forecast by Region, 2017-2025
4.2.Anesthetics
4.2.1. Historical Market Size by Region, 2014-2016
4.2.2. Market Forecast by Region, 2017-2025
4.3.Anticonvulsants
4.3.1. Historical Market Size by Region, 2014-2016
4.3.2. Market Forecast by Region, 2017-2025
4.4.Antimigraine Agents
4.4.1. Historical Market Size by Region, 2014-2016
4.4.2. Market Forecast by Region, 2017-2025
4.5.Antidepressants
4.5.1. Historical Market Size by Region, 2014-2016
4.5.2. Market Forecast by Region, 2017-2025
4.6.Opioids
4.6.1. Historical Market Size by Region, 2014-2016
4.6.2. Market Forecast by Region, 2017-2025
4.7.Nonnarcotic Analgesics
4.7.1. Historical Market Size by Region, 2014-2016
4.7.2. Market Forecast by Region, 2017-2025
5. GLOBAL PAIN MANAGEMENT DRUGS MARKET BY INDICATION
5.1.Arthritic Pain
5.1.1. Historical Market Size by Region, 2014-2016
5.1.2. Market Forecast by Region, 2017-2025
5.2.Neuropathic Pain
5.2.1. Historical Market Size by Region, 2014-2016
5.2.2. Market Forecast by Region, 2017-2025
5.3.Cancer Pain
5.3.1. Historical Market Size by Region, 2014-2016
5.3.2. Market Forecast by Region, 2017-2025
5.4.Chronic Back Pain
5.4.1. Historical Market Size by Region, 2014-2016
5.4.2. Market Forecast by Region, 2017-2025
5.5.Postoperative Pain
5.5.1. Historical Market Size by Region, 2014-2016
5.5.2. Market Forecast by Region, 2017-2025
5.6.Migraine
5.6.1. Historical Market Size by Region, 2014-2016
5.6.2. Market Forecast by Region, 2017-2025
5.7.Fibromyalgia
5.7.1. Historical Market Size by Region, 2014-2016
5.7.2. Market Forecast by Region, 2017-2025
6. GLOBAL PAIN MANAGEMENT DRUGS MARKET BY GEOGRAPHY
6.1.North America
6.1.1. U.S.
6.1.1.1. Historical Market Size, 2014-2016
6.1.1.2. Market Forecast, 2017-2025
6.1.2. Canada
6.1.2.1. Historical Market Size, 2014-2016
6.1.2.2. Market Forecast, 2017-2025
6.1.3. Mexico
6.1.3.1. Historical Market Size, 2014-2016
6.1.3.2. Market Forecast, 2017-2025
6.2.Europe
6.2.1. UK
6.2.1.1. Historical Market Size, 2014-2016
6.2.1.2. Market Forecast, 2017-2025
6.2.2. Germany
6.2.2.1. Historical Market Size, 2014-2016
6.2.2.2. Market Forecast, 2017-2025
6.2.3. France
6.2.3.1. Historical Market Size, 2014-2016
6.2.3.2. Market Forecast, 2017-2025
6.2.4. Spain
6.2.4.1. Historical Market Size, 2014-2016
6.2.4.2. Market Forecast, 2017-2025
6.2.5. Italy
6.2.5.1. Historical Market Size, 2014-2016
6.2.5.2. Market Forecast, 2017-2025
6.2.6. Rest of Europe
6.2.6.1. Historical Market Size, 2014-2016
6.2.6.2. Market Forecast, 2017-2025
6.3.Asia-Pacific
6.3.1. China
6.3.1.1. Historical Market Size, 2014-2016
6.3.1.2. Market Forecast, 2017-2025
6.3.2. Japan
6.3.2.1. Historical Market Size, 2014-2016
6.3.2.2. Market Forecast, 2017-2025
6.3.3. India
6.3.3.1. Historical Market Size, 2014-2016
6.3.3.2. Market Forecast, 2017-2025
6.3.4. Australia
6.3.4.1. Historical Market Size, 2014-2016
6.3.4.2. Market Forecast, 2017-2025
6.3.5. Taiwan
6.3.5.1. Historical Market Size, 2014-2016
6.3.5.2. Market Forecast, 2017-2025
6.3.6. Rest of Asia-Pacific
6.3.6.1. Historical Market Size, 2014-2016
6.3.6.2. Market Forecast, 2017-2025
6.4.LAMEA
6.4.1. Brazil
6.4.1.1. Historical Market Size, 2014-2016
6.4.1.2. Market Forecast, 2017-2025
6.4.2. South Arabia
6.4.2.1. Historical Market Size, 2014-2016
6.4.2.2. Market Forecast, 2017-2025
6.4.3. South Africa
6.4.3.1. Historical Market Size, 2014-2016
6.4.3.2. Market Forecast, 2017-2025
6.4.4. Rest of LAMEA
6.4.4.1. Historical Market Size, 2014-2016
6.4.4.2. Market Forecast, 2017-2025
7. COMPANY PROFILES
7.1.Novartis AG
7.1.1. Overview
7.1.2. Financials and business segments
7.1.3. Recent developments
7.2.Eli Lilly & Company
7.2.1. Overview
7.2.2. Financials and business segments
7.2.3. Recent developments
7.3.Abbott Laboratories
7.3.1. Overview
7.3.2. Financials and business segments
7.3.3. Recent developments
7.4.Endo Health Solutions, Inc.
7.4.1. Overview
7.4.2. Financials and business segments
7.4.3. Recent developments
7.5.Purdue Pharma L.P.
7.5.1. Overview
7.5.2. Financials and business segments
7.5.3. Recent developments
7.6.Pfizer, Inc.
7.6.1. Overview
7.6.2. Financials and business segments
7.6.3. Recent developments
7.7.F. Hoffmann La Roche Ltd.
7.7.1. Overview
7.7.2. Financials and business segments
7.7.3. Recent developments
7.8.Merck & Co. Inc.
7.8.1. Overview
7.8.2. Financials and business segments
7.8.3. Recent developments
7.9.Johnson & Johnson
7.9.1. Overview
7.9.2. Financials and business segments
7.9.3. Recent developments
7.10.GlaxoSmithKline plc
7.10.1. Overview
7.10.2. Financials and business segments
7.10.3. Recent developments
1.1.Key Findings
1.2.Market Attractiveness and Trend analysis
1.3.Competitive Landscape and recent industry development analysis
2. INTRODUCTION
2.1.Report Description
2.2.Scope and Definitions
2.3.Research Methodology
3. MARKET LANDSCAPE
3.1.Growth Drivers
3.1.1. Impact Analysis
3.2.Restrains and Challenges
3.2.1. Impact Analysis
3.3.Porter’s Analysis
3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Industry rivalry
3.3.5. Threat of new entrants
3.4.Global Pain Management Drugs Market Shares Analysis, 2014-2025
3.4.1. Global Pain Management Drugs Market by drug class, 2014-2025
3.4.2. Global Pain Management Drugs Market by indication, 2014-2025
3.4.3. Global Pain Management Drugs Market by region, 2014-2025
4. GLOBAL PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS
4.1.NSAIDs
4.1.1. Historical Market Size by Region, 2014-2016
4.1.2. Market Forecast by Region, 2017-2025
4.2.Anesthetics
4.2.1. Historical Market Size by Region, 2014-2016
4.2.2. Market Forecast by Region, 2017-2025
4.3.Anticonvulsants
4.3.1. Historical Market Size by Region, 2014-2016
4.3.2. Market Forecast by Region, 2017-2025
4.4.Antimigraine Agents
4.4.1. Historical Market Size by Region, 2014-2016
4.4.2. Market Forecast by Region, 2017-2025
4.5.Antidepressants
4.5.1. Historical Market Size by Region, 2014-2016
4.5.2. Market Forecast by Region, 2017-2025
4.6.Opioids
4.6.1. Historical Market Size by Region, 2014-2016
4.6.2. Market Forecast by Region, 2017-2025
4.7.Nonnarcotic Analgesics
4.7.1. Historical Market Size by Region, 2014-2016
4.7.2. Market Forecast by Region, 2017-2025
5. GLOBAL PAIN MANAGEMENT DRUGS MARKET BY INDICATION
5.1.Arthritic Pain
5.1.1. Historical Market Size by Region, 2014-2016
5.1.2. Market Forecast by Region, 2017-2025
5.2.Neuropathic Pain
5.2.1. Historical Market Size by Region, 2014-2016
5.2.2. Market Forecast by Region, 2017-2025
5.3.Cancer Pain
5.3.1. Historical Market Size by Region, 2014-2016
5.3.2. Market Forecast by Region, 2017-2025
5.4.Chronic Back Pain
5.4.1. Historical Market Size by Region, 2014-2016
5.4.2. Market Forecast by Region, 2017-2025
5.5.Postoperative Pain
5.5.1. Historical Market Size by Region, 2014-2016
5.5.2. Market Forecast by Region, 2017-2025
5.6.Migraine
5.6.1. Historical Market Size by Region, 2014-2016
5.6.2. Market Forecast by Region, 2017-2025
5.7.Fibromyalgia
5.7.1. Historical Market Size by Region, 2014-2016
5.7.2. Market Forecast by Region, 2017-2025
6. GLOBAL PAIN MANAGEMENT DRUGS MARKET BY GEOGRAPHY
6.1.North America
6.1.1. U.S.
6.1.1.1. Historical Market Size, 2014-2016
6.1.1.2. Market Forecast, 2017-2025
6.1.2. Canada
6.1.2.1. Historical Market Size, 2014-2016
6.1.2.2. Market Forecast, 2017-2025
6.1.3. Mexico
6.1.3.1. Historical Market Size, 2014-2016
6.1.3.2. Market Forecast, 2017-2025
6.2.Europe
6.2.1. UK
6.2.1.1. Historical Market Size, 2014-2016
6.2.1.2. Market Forecast, 2017-2025
6.2.2. Germany
6.2.2.1. Historical Market Size, 2014-2016
6.2.2.2. Market Forecast, 2017-2025
6.2.3. France
6.2.3.1. Historical Market Size, 2014-2016
6.2.3.2. Market Forecast, 2017-2025
6.2.4. Spain
6.2.4.1. Historical Market Size, 2014-2016
6.2.4.2. Market Forecast, 2017-2025
6.2.5. Italy
6.2.5.1. Historical Market Size, 2014-2016
6.2.5.2. Market Forecast, 2017-2025
6.2.6. Rest of Europe
6.2.6.1. Historical Market Size, 2014-2016
6.2.6.2. Market Forecast, 2017-2025
6.3.Asia-Pacific
6.3.1. China
6.3.1.1. Historical Market Size, 2014-2016
6.3.1.2. Market Forecast, 2017-2025
6.3.2. Japan
6.3.2.1. Historical Market Size, 2014-2016
6.3.2.2. Market Forecast, 2017-2025
6.3.3. India
6.3.3.1. Historical Market Size, 2014-2016
6.3.3.2. Market Forecast, 2017-2025
6.3.4. Australia
6.3.4.1. Historical Market Size, 2014-2016
6.3.4.2. Market Forecast, 2017-2025
6.3.5. Taiwan
6.3.5.1. Historical Market Size, 2014-2016
6.3.5.2. Market Forecast, 2017-2025
6.3.6. Rest of Asia-Pacific
6.3.6.1. Historical Market Size, 2014-2016
6.3.6.2. Market Forecast, 2017-2025
6.4.LAMEA
6.4.1. Brazil
6.4.1.1. Historical Market Size, 2014-2016
6.4.1.2. Market Forecast, 2017-2025
6.4.2. South Arabia
6.4.2.1. Historical Market Size, 2014-2016
6.4.2.2. Market Forecast, 2017-2025
6.4.3. South Africa
6.4.3.1. Historical Market Size, 2014-2016
6.4.3.2. Market Forecast, 2017-2025
6.4.4. Rest of LAMEA
6.4.4.1. Historical Market Size, 2014-2016
6.4.4.2. Market Forecast, 2017-2025
7. COMPANY PROFILES
7.1.Novartis AG
7.1.1. Overview
7.1.2. Financials and business segments
7.1.3. Recent developments
7.2.Eli Lilly & Company
7.2.1. Overview
7.2.2. Financials and business segments
7.2.3. Recent developments
7.3.Abbott Laboratories
7.3.1. Overview
7.3.2. Financials and business segments
7.3.3. Recent developments
7.4.Endo Health Solutions, Inc.
7.4.1. Overview
7.4.2. Financials and business segments
7.4.3. Recent developments
7.5.Purdue Pharma L.P.
7.5.1. Overview
7.5.2. Financials and business segments
7.5.3. Recent developments
7.6.Pfizer, Inc.
7.6.1. Overview
7.6.2. Financials and business segments
7.6.3. Recent developments
7.7.F. Hoffmann La Roche Ltd.
7.7.1. Overview
7.7.2. Financials and business segments
7.7.3. Recent developments
7.8.Merck & Co. Inc.
7.8.1. Overview
7.8.2. Financials and business segments
7.8.3. Recent developments
7.9.Johnson & Johnson
7.9.1. Overview
7.9.2. Financials and business segments
7.9.3. Recent developments
7.10.GlaxoSmithKline plc
7.10.1. Overview
7.10.2. Financials and business segments
7.10.3. Recent developments
LIST OF TABLES
Table 1. Pain Management DrugsMarket Value, by Drug Class, 2014-2025, $million
Table 2. Pain Management DrugsMarket Value, by Indication, 2014-2025, $million
Table 3. Pain Management DrugsMarket Value, by Region, 2014-2025, $million
Table 4. Pain Management DrugsMarket Valuefor NSAIDs, by Region, 2017-2025, $million
Table 5. Pain Management DrugsMarket Valuefor Anesthetics, by Type, 2017-2025, $million
Table 6. Pain Management DrugsMarket Valuefor Anticonvulsants, by Region, 2017-2025, $million
Table 7. Pain Management DrugsMarket Valuefor Antimigraine Agents, by Type, 2017-2025, $million
Table 8. Pain Management DrugsMarket Valuefor Antidepressants, by Region, 2017-2025, $million
Table 9. Pain Management DrugsMarket Valuefor Opioids, by Type, 2017-2025, $million
Table 10. Pain Management DrugsMarket Valuefor Nonnarcotic Analgesics, by Region, 2017-2025, $million
Table 11. Pain Management DrugsMarket Valuefor Arthritic Pain, by Region, 2017-2025, $million
Table 12. Pain Management DrugsMarket Valuefor Neuropathic Pain, by Region, 2017-2025, $million
Table 13. Pain Management DrugsMarket Valuefor Cancer Pain, by Region, 2017-2025, $million
Table 14. Pain Management DrugsMarket Valuefor Chronic Back Pain, by Type, 2017-2025, $million
Table 15. Pain Management DrugsMarket Valuefor Postoperative Pain, by Region, 2017-2025, $million
Table 16. Pain Management DrugsMarket Valuefor Migraine, by Region, 2017-2025, $million
Table 17. Pain Management DrugsMarket Valuefor Fibromyalgia, by Region, 2017-2025, $million
Table 18. Pain Management DrugsMarket Valuefor North America, by Country, 2017-2025, $million
Table 19. Pain Management DrugsMarket Valuefor North America, by Drug Class, 2017-2025, $million
Table 20. Pain Management DrugsMarket Valuefor North America, by Indication, 2017-2025, $million
Table 21. Pain Management DrugsMarket Valuefor Europe, by Country, 2017-2025, $million
Table 22. Pain Management DrugsMarket Valuefor Europe, by Drug Class, 2017-2025, $million
Table 23. Pain Management DrugsMarket Valuefor Europe, by Indication, 2017-2025, $million
Table 24. Pain Management DrugsMarket Valuefor Asia-Pacific, by Country, 2017-2025, $million
Table 25. Pain Management DrugsMarket Valuefor Asia-Pacific, by Drug Class, 2017-2025, $million
Table 26. Pain Management DrugsMarket Valuefor Asia-Pacific, by Indication, 2017-2025, $million
Table 27. Pain Management DrugsMarket Valuefor LAMEA, by Country, 2017-2025, $million
Table 28. Pain Management DrugsMarket Valuefor LAMEA, by Drug Class, 2017-2025, $million
Table 29. Pain Management DrugsMarket Valuefor LAMEA, by Indication, 2017-2025, $million
Table 30. Novartis AG - Company Snapshot
Table 31. Eli Lilly & Company - Company Snapshot
Table 32. Abbott Laboratories - Company Snapshot
Table 33. Endo Health Solutions, Inc. - Company Snapshot
Table 34. Purdue Pharma L.P. - Company Snapshot
Table 35. Pfizer, Inc. - Company Snapshot
Table 36. F. Hoffmann La Roche Ltd. - Company Snapshot
Table 37. Merck & Co. Inc. - Company Snapshot
Table 38. Johnson & Johnson - Company Snapshot
Table 39. GlaxoSmithKline plc - Company Snapshot
Table 1. Pain Management DrugsMarket Value, by Drug Class, 2014-2025, $million
Table 2. Pain Management DrugsMarket Value, by Indication, 2014-2025, $million
Table 3. Pain Management DrugsMarket Value, by Region, 2014-2025, $million
Table 4. Pain Management DrugsMarket Valuefor NSAIDs, by Region, 2017-2025, $million
Table 5. Pain Management DrugsMarket Valuefor Anesthetics, by Type, 2017-2025, $million
Table 6. Pain Management DrugsMarket Valuefor Anticonvulsants, by Region, 2017-2025, $million
Table 7. Pain Management DrugsMarket Valuefor Antimigraine Agents, by Type, 2017-2025, $million
Table 8. Pain Management DrugsMarket Valuefor Antidepressants, by Region, 2017-2025, $million
Table 9. Pain Management DrugsMarket Valuefor Opioids, by Type, 2017-2025, $million
Table 10. Pain Management DrugsMarket Valuefor Nonnarcotic Analgesics, by Region, 2017-2025, $million
Table 11. Pain Management DrugsMarket Valuefor Arthritic Pain, by Region, 2017-2025, $million
Table 12. Pain Management DrugsMarket Valuefor Neuropathic Pain, by Region, 2017-2025, $million
Table 13. Pain Management DrugsMarket Valuefor Cancer Pain, by Region, 2017-2025, $million
Table 14. Pain Management DrugsMarket Valuefor Chronic Back Pain, by Type, 2017-2025, $million
Table 15. Pain Management DrugsMarket Valuefor Postoperative Pain, by Region, 2017-2025, $million
Table 16. Pain Management DrugsMarket Valuefor Migraine, by Region, 2017-2025, $million
Table 17. Pain Management DrugsMarket Valuefor Fibromyalgia, by Region, 2017-2025, $million
Table 18. Pain Management DrugsMarket Valuefor North America, by Country, 2017-2025, $million
Table 19. Pain Management DrugsMarket Valuefor North America, by Drug Class, 2017-2025, $million
Table 20. Pain Management DrugsMarket Valuefor North America, by Indication, 2017-2025, $million
Table 21. Pain Management DrugsMarket Valuefor Europe, by Country, 2017-2025, $million
Table 22. Pain Management DrugsMarket Valuefor Europe, by Drug Class, 2017-2025, $million
Table 23. Pain Management DrugsMarket Valuefor Europe, by Indication, 2017-2025, $million
Table 24. Pain Management DrugsMarket Valuefor Asia-Pacific, by Country, 2017-2025, $million
Table 25. Pain Management DrugsMarket Valuefor Asia-Pacific, by Drug Class, 2017-2025, $million
Table 26. Pain Management DrugsMarket Valuefor Asia-Pacific, by Indication, 2017-2025, $million
Table 27. Pain Management DrugsMarket Valuefor LAMEA, by Country, 2017-2025, $million
Table 28. Pain Management DrugsMarket Valuefor LAMEA, by Drug Class, 2017-2025, $million
Table 29. Pain Management DrugsMarket Valuefor LAMEA, by Indication, 2017-2025, $million
Table 30. Novartis AG - Company Snapshot
Table 31. Eli Lilly & Company - Company Snapshot
Table 32. Abbott Laboratories - Company Snapshot
Table 33. Endo Health Solutions, Inc. - Company Snapshot
Table 34. Purdue Pharma L.P. - Company Snapshot
Table 35. Pfizer, Inc. - Company Snapshot
Table 36. F. Hoffmann La Roche Ltd. - Company Snapshot
Table 37. Merck & Co. Inc. - Company Snapshot
Table 38. Johnson & Johnson - Company Snapshot
Table 39. GlaxoSmithKline plc - Company Snapshot
LIST OF FIGURES
Figure 1. Pain Management Drugs: NSAIDs Market Value, 2014-2016, $million
Figure 2. Pain Management Drugs: Anesthetics Market Value, 2014-2016, $million
Figure 3. Pain Management Drugs: Anticonvulsants Market Value, 2014-2016, $million
Figure 4. Pain Management Drugs: Antimigraine Agents Market Value, 2014-2017, $million
Figure 5. Pain Management Drugs: Antidepressants Market Value, 2014-2018, $million
Figure 6. Pain Management Drugs: Opioids Market Value, 2014-2019, $million
Figure 7. Pain Management Drugs: Nonnarcotic Analgesics Market Value, 2014-2020, $million
Figure 8. Pain Management Drugs: Arthritic Pain Market Value, 2014-2021, $million
Figure 9. Pain Management Drugs: Neuropathic Pain Market Value, 2014-2022, $million
Figure 10. Pain Management Drugs: Cancer Pain Market Value, 2014-2023, $million
Figure 11. Pain Management Drugs: Chronic Back Pain Market Value, 2014-2024, $million
Figure 12. Pain Management Drugs: Postoperative Pain Market Value, 2014-2025, $million
Figure 13. Pain Management Drugs: Migraine Market Value, 2014-2026, $million
Figure 14. Pain Management Drugs: Fibromyalgia Market Value, 2014-2027, $million
Figure 15. Pain Management Drugs: U.S. Market Value, 2014-2016, $million
Figure 16. Pain Management Drugs: U.S. Market Value, 2017-2025, $million
Figure 17. Pain Management Drugs: Canada Market Value, 2014-2016, $million
Figure 18. Pain Management Drugs: Canada Market Value, 2017-2025, $million
Figure 19. Pain Management Drugs: Mexico Market Value, 2014-2016, $million
Figure 20. Pain Management Drugs: Mexico Market Value, 2017-2025, $million
Figure 21. Pain Management Drugs: UK Market Value, 2014-2016, $million
Figure 22. Pain Management Drugs: UK Market Value, 2017-2025, $million
Figure 23. Pain Management Drugs: Germany Market Value, 2014-2016, $million
Figure 24. Pain Management Drugs: Germany Market Value, 2017-2025, $million
Figure 25. Pain Management Drugs: France Market Value, 2014-2016, $million
Figure 26. Pain Management Drugs: France Market Value, 2017-2025, $million
Figure 27. Pain Management Drugs: Spain Market Value, 2014-2016, $million
Figure 28. Pain Management Drugs: Spain Market Value, 2017-2025, $million
Figure 29. Pain Management Drugs: Italy Market Value, 2014-2016, $million
Figure 30. Pain Management Drugs: Italy Market Value, 2017-2025, $million
Figure 31. Pain Management Drugs: Rest of Europe Market Value, 2014-2016, $million
Figure 32. Pain Management Drugs: Rest of Europe Market Value, 2017-2025, $million
Figure 33. Pain Management Drugs: China Market Value, 2014-2016, $million
Figure 34. Pain Management Drugs: China Market Value, 2017-2025, $million
Figure 35. Pain Management Drugs: Japan Market Value, 2014-2016, $million
Figure 36. Pain Management Drugs: Japan Market Value, 2017-2025, $million
Figure 37. Pain Management Drugs: India Market Value, 2014-2016, $million
Figure 38. Pain Management Drugs: India Market Value, 2017-2025, $million
Figure 39. Pain Management Drugs: Australia Market Value, 2014-2016, $million
Figure 40. Pain Management Drugs: Australia Market Value, 2017-2025, $million
Figure 41. Pain Management Drugs: Taiwan Market Value, 2014-2016, $million
Figure 42. Pain Management Drugs: Taiwan Market Value, 2017-2025, $million
Figure 43. Pain Management Drugs: Rest of Asia-Pacific Market Value, 2014-2016, $million
Figure 44. Pain Management Drugs: Rest of Asia-Pacific Market Value, 2017-2025, $million
Figure 45. Pain Management Drugs: Brazil Market Value, 2014-2016, $million
Figure 46. Pain Management Drugs: Brazil Market Value, 2017-2025, $million
Figure 47. Pain Management Drugs: Saudi Arabia Market Value, 2014-2016, $million
Figure 48. Pain Management Drugs: Saudi Arabia Market Value, 2017-2025, $million
Figure 49. Pain Management Drugs: South Africa Market Value, 2014-2016, $million
Figure 50. Pain Management Drugs: South Africa Market Value, 2017-2025, $million
Figure 51. Pain Management Drugs: Rest of LAMEA Market Value, 2014-2016, $million
Figure 52. Pain Management Drugs: Rest of LAMEA Market Value, 2017-2025, $million
Figure 1. Pain Management Drugs: NSAIDs Market Value, 2014-2016, $million
Figure 2. Pain Management Drugs: Anesthetics Market Value, 2014-2016, $million
Figure 3. Pain Management Drugs: Anticonvulsants Market Value, 2014-2016, $million
Figure 4. Pain Management Drugs: Antimigraine Agents Market Value, 2014-2017, $million
Figure 5. Pain Management Drugs: Antidepressants Market Value, 2014-2018, $million
Figure 6. Pain Management Drugs: Opioids Market Value, 2014-2019, $million
Figure 7. Pain Management Drugs: Nonnarcotic Analgesics Market Value, 2014-2020, $million
Figure 8. Pain Management Drugs: Arthritic Pain Market Value, 2014-2021, $million
Figure 9. Pain Management Drugs: Neuropathic Pain Market Value, 2014-2022, $million
Figure 10. Pain Management Drugs: Cancer Pain Market Value, 2014-2023, $million
Figure 11. Pain Management Drugs: Chronic Back Pain Market Value, 2014-2024, $million
Figure 12. Pain Management Drugs: Postoperative Pain Market Value, 2014-2025, $million
Figure 13. Pain Management Drugs: Migraine Market Value, 2014-2026, $million
Figure 14. Pain Management Drugs: Fibromyalgia Market Value, 2014-2027, $million
Figure 15. Pain Management Drugs: U.S. Market Value, 2014-2016, $million
Figure 16. Pain Management Drugs: U.S. Market Value, 2017-2025, $million
Figure 17. Pain Management Drugs: Canada Market Value, 2014-2016, $million
Figure 18. Pain Management Drugs: Canada Market Value, 2017-2025, $million
Figure 19. Pain Management Drugs: Mexico Market Value, 2014-2016, $million
Figure 20. Pain Management Drugs: Mexico Market Value, 2017-2025, $million
Figure 21. Pain Management Drugs: UK Market Value, 2014-2016, $million
Figure 22. Pain Management Drugs: UK Market Value, 2017-2025, $million
Figure 23. Pain Management Drugs: Germany Market Value, 2014-2016, $million
Figure 24. Pain Management Drugs: Germany Market Value, 2017-2025, $million
Figure 25. Pain Management Drugs: France Market Value, 2014-2016, $million
Figure 26. Pain Management Drugs: France Market Value, 2017-2025, $million
Figure 27. Pain Management Drugs: Spain Market Value, 2014-2016, $million
Figure 28. Pain Management Drugs: Spain Market Value, 2017-2025, $million
Figure 29. Pain Management Drugs: Italy Market Value, 2014-2016, $million
Figure 30. Pain Management Drugs: Italy Market Value, 2017-2025, $million
Figure 31. Pain Management Drugs: Rest of Europe Market Value, 2014-2016, $million
Figure 32. Pain Management Drugs: Rest of Europe Market Value, 2017-2025, $million
Figure 33. Pain Management Drugs: China Market Value, 2014-2016, $million
Figure 34. Pain Management Drugs: China Market Value, 2017-2025, $million
Figure 35. Pain Management Drugs: Japan Market Value, 2014-2016, $million
Figure 36. Pain Management Drugs: Japan Market Value, 2017-2025, $million
Figure 37. Pain Management Drugs: India Market Value, 2014-2016, $million
Figure 38. Pain Management Drugs: India Market Value, 2017-2025, $million
Figure 39. Pain Management Drugs: Australia Market Value, 2014-2016, $million
Figure 40. Pain Management Drugs: Australia Market Value, 2017-2025, $million
Figure 41. Pain Management Drugs: Taiwan Market Value, 2014-2016, $million
Figure 42. Pain Management Drugs: Taiwan Market Value, 2017-2025, $million
Figure 43. Pain Management Drugs: Rest of Asia-Pacific Market Value, 2014-2016, $million
Figure 44. Pain Management Drugs: Rest of Asia-Pacific Market Value, 2017-2025, $million
Figure 45. Pain Management Drugs: Brazil Market Value, 2014-2016, $million
Figure 46. Pain Management Drugs: Brazil Market Value, 2017-2025, $million
Figure 47. Pain Management Drugs: Saudi Arabia Market Value, 2014-2016, $million
Figure 48. Pain Management Drugs: Saudi Arabia Market Value, 2017-2025, $million
Figure 49. Pain Management Drugs: South Africa Market Value, 2014-2016, $million
Figure 50. Pain Management Drugs: South Africa Market Value, 2017-2025, $million
Figure 51. Pain Management Drugs: Rest of LAMEA Market Value, 2014-2016, $million
Figure 52. Pain Management Drugs: Rest of LAMEA Market Value, 2017-2025, $million
